Disease: Tardive dyskinesia
- <em>NKX2-1</em>-Related Disorders
- A Bioequivalence Comparison Between the Once-Daily Extended-Release Tablet and the Twice-Daily Tablet Formulations of Deutetrabenazine at Steady State
- A descriptive analysis of spontaneous reports of antipsychotic-induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database
- Accelerated anodal transcranial direct current stimulation targeting cerebellum and primary motor cortex in the management of tardive dyskinesia: A case study
- Akathisia
- An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders
- Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesia
- Associations between Catechol-O-methyltransferase (COMT) polymorphisms and cognitive impairments, psychiatric symptoms and tardive dyskinesia in schizophrenia
- Associations between polymorphisms in the cannabinoid receptor 1 gene, cognitive impairments and tardive dyskinesia in a Chinese population with schizophrenia
- Atypical extrapyramidal manifestation of a typical antipsychotic with serotonergic antidepressant
- Bacillus Calmette-Guérin Vaccine Attenuates Haloperidol-Induced TD-like Behavioral and Neurochemical Alteration in Experimental Rats
- Bridging the gap between statistical significance and clinical relevance: A systematic review of minimum clinically important difference (MCID) thresholds of scales reported in movement disorders research
- Clebopride-Associated Movement Disorders
- Clinical quandaries in psychotic disorders: the road is long, with many a winding turn
- Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia
- Clozapine
- Clozapine Prescripers-Dogmatic or Pragmatic?
- Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 Inhibitors for Tardive Dyskinesia: A Systematic Review
- Crushing the Contents of Valbenazine Capsules for Potential Addition to Soft Foods or Administration via Gastrostomy Tube
- Delayed Presentation of Antipsychotic Withdrawal Tardive Dyskinesia: A Case Report
- Early Onset of Tardive Dyskinesia in an Antipsychotic-Naive Patient Treated With Low-Dose Cariprazine
- Effect of rs1108580 of DBH and rs1006737 of CACNA1C on Cognition and Tardive Dyskinesia in a North Indian Schizophrenia Cohort
- Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial
- Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder: Primary Results and Post Hoc Analyses of the J-KINECT Study
- Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review
- Extrapyramidal Symptoms
- First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
- Frontotemporal Hypometabolism in Medication-Induced Tardive Dyskinesia
- Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
- Genome-wide DNA methylation analysis in schizophrenia with tardive dyskinesia: a preliminary study
- Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications
- Illustration of the Dramatic and Dynamic Efficacy of Chronic GPi-DBS Therapy in a Patient with Tardive Dyskinesia/Dystonia
- Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States
- Implementation of Pharmacist-Led Medication Review Service for Parkinson's Disease Patients Admitted for Deep Brain Stimulation
- Improvement of Tardive Dyskinesias with Olanzapine
- Increasing Abnormal Involuntary Movement Scale (AIMS) Screening for Tardive Dyskinesia in an Outpatient Psychiatry Clinic: A Resident-Led Outpatient Lean Six Sigma Initiative
- Integrative approach for managing tardive dyskinesia: A case report
- Investigating Real-World Benztropine Usage Patterns in Movement Disorders: Claims Analysis and Health Care Provider Survey Results
- Involvement of Antioxidant and Prevention of Mitochondrial Dysfunction, Anti-Neuroinflammatory Effect and Anti-Apoptotic Effect: Betaine Ameliorates Haloperidol-Induced Orofacial Dyskinesia in Rats
- Levodopa/Carbidopa to Augment the Treatment of Amblyopia: A Report by the American Academy of Ophthalmology
- Management of Cholinergic Rebound After Abrupt Withdrawal of Clozapine: A Case Report and Systematic Literature Review
- Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis
- Metoclopramide
- Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database
- Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: A case report
- Neglect of Adverse Effects in Treatment Guidelines for Depression
- Neurological perspectives should be integrated into the management of tardive dyskinesia - expert opinion and proposed educational initiatives in Asia
- Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review
- Oleanolic acid alleviates the extrapyramidal symptoms and cognitive impairment induced by haloperidol through the striatal PKA signaling pathway in mice
- Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
- Overview of Movement Disorders Secondary to Drugs
- Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation
- Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
- Putative role of immune reactions in the mechanism of tardive dyskinesia
- Real-world experience with VMAT2 inhibitors in Tourette syndrome
- Regional Homogeneity in schizophrenia patients with tardive dyskinesia: a resting-state fMRI study
- Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine: A Case Report
- Reversible Dysphagia Associated With Risperidone Presenting With a Choking Episode
- Review of Dopamine Antagonists for Nausea and Vomiting in Palliative Care Patients
- Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
- Safety assessment of Brexpiprazole: Real-world adverse event analysis from the FAERS database
- Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
- Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia
- Tardive dyskinesia
- Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway
- Tardive Dyskinesia Suppressed With Ginkgo Biloba
- Tardive Dyskinesia Suppressed With Ginkgo Biloba
- Tardive Dyskinesia With Chorea-Ballism Improved by Valbenazine: A Case Report
- Tardive dyskinesia's under-recognition in the era of COVID-19
- The Challenge of Managing Refractory Psychosis Amid Multiple Medication Side Effects: A Case Report and Review of the Literature
- The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia
- The effect of Oenothera biennis (Evening primrose) oil on inflammatory diseases: a systematic review of clinical trials
- The Extrapyramidal Symptom Rating Scale and Its Abbreviated Version: A Critical Review of Clinimetric Properties
- The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences
- The Outcome of Antipsychotics-induced Tardive Syndromes: A Ten-year Follow-up Study
- The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
- The value of re-evaluation and thorough family history taking for the diagnostic work-up of chorea
- Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines
- Treatment of severe tardive dyskinesia with concurrent administration of olanzapine, clonazepam, baclofen, and gabapentin: a case report
- Unveiling the Unprecedented: An Astonishing Rarity of Metoclopramide Hydrochloride-Triggered Nystagmus in a Pregnant Woman
- Valbenazine for tardive dyskinesia: a systematic review and network meta-analysis
- Valbenazine promotes body growth via growth hormone signaling during zebrafish embryonic development
- Zolpidem dependence for self-medication in the management of tardive dyskinesia